Publication of Investor Presentation
March 09 2021 - 2:00AM
Publication of Investor Presentation
DXS INTERNATIONAL PLC
(AQSE: DXSP)
Publication of Investor
Presentation
DXS International plc ("DXSP" or the "Company"), the AQSE quoted
clinical decision support developer and supplier of clinical
decision support systems, is pleased to confirm that an updated
corporate presentation is now available for download from the
Corporate Documents section of the Company’s website
at https://www.dxs-systems.co.uk/corporate-documents.php
Contacts:
| David
Immelman (Chief
Executive)DXS International plc |
01252 719800david@dxs-systems.com |
|
https://www.dxs-systems.co.uk |
|
| Corporate
Advisor |
|
| City &
Merchant David Papworth |
020 7101 7676 |
| Corporate
Broker |
|
| Hybridan
LLPClaire Louise Noyce |
020 3764 2341 |
Notes to Editors
About DXS:
DXS International presents up to date treatment
guidelines and recommendations, from Clinical Commissioning Groups
and other trusted NHS sources, to doctors, nurses and pharmacists
in their workflow and during the patient consultation. This
effective clinical decision support ultimately translates to
improved healthcare outcomes delivered more cost effectively and
which should significantly contribute towards the NHS achieving its
projected efficiency savings.
DXS (AQSE:DXSP)
Historical Stock Chart
From Jun 2024 to Jul 2024
DXS (AQSE:DXSP)
Historical Stock Chart
From Jul 2023 to Jul 2024
